As the global economy mends, the 2021 growth of Lateral Flow Rapid Testing will have significant change from previous year. According to our (LP Information) latest study, the global Lateral Flow Rapid Testing market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Lateral Flow Rapid Testing market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Lateral Flow Rapid Testing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Lateral Flow Rapid Testing market, reaching US$ million by the year 2028. As for the Europe Lateral Flow Rapid Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Lateral Flow Rapid Testing players cover Mologic, Thermo Fisher Scientific, Bio-Rad Laboratories, and Svar Life Science, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Lateral Flow Rapid Testing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Sandwich Immunoassay
Competitive Immunoassay
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Specialty Clinics
Diagnostic Centers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Mologic
Thermo Fisher Scientific
Bio-Rad Laboratories
Svar Life Science
Abbott Laboratories
Roche
Danaher
Siemens Healthcare
BD
R-Biopharma
Cell Biolabs
BioMerieux
Merck
Qiagen
Summary:
Get latest Market Research Reports on Lateral Flow Rapid Testing. Industry analysis & Market Report on Lateral Flow Rapid Testing is a syndicated market report, published as Global Lateral Flow Rapid Testing Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Lateral Flow Rapid Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.